Clarence Jones

Yeah. I'm sorry. So the question for me was, you know, in our community, we're still struggling with this issue. And the question is, what is it that we should be doing around prostate cancer?

Yeah. I'm sorry. So the question for me was, you know, in our community, we're still struggling with this issue. And the question is, what is it that we should be doing around prostate cancer?

Absolutely. Yeah. I'm really excited, Dr. Robert. I want to thank you for actually being on our show today. And I know that this is a conversation that is very complex, but it's also for a lot of people very emotional.

Absolutely. Yeah. I'm really excited, Dr. Robert. I want to thank you for actually being on our show today. And I know that this is a conversation that is very complex, but it's also for a lot of people very emotional.

And I think that I was trying to convey that in terms of some of the conversations that I was having that as important as this issue is, we have to continue to find ways to get people to enter the conversation. And part of the work that you're doing does that. I mean, the idea of working specifically around a topic of interest to me really excited me about working with you.

And I think that I was trying to convey that in terms of some of the conversations that I was having that as important as this issue is, we have to continue to find ways to get people to enter the conversation. And part of the work that you're doing does that. I mean, the idea of working specifically around a topic of interest to me really excited me about working with you.

But I also understand the bigger ramification of what we're trying to do. And so I just want to personally thank you for the work that you've done. And I know that we're going to be disseminating this information back to the community. One is when just kind of a midterm report, whatever. And then when the other report comes out, we're going to do that.

But I also understand the bigger ramification of what we're trying to do. And so I just want to personally thank you for the work that you've done. And I know that we're going to be disseminating this information back to the community. One is when just kind of a midterm report, whatever. And then when the other report comes out, we're going to do that.

But that's part of what, you know, Stan, your question is that we're going to disseminate this information. And we told the participants in this study that we were going to disseminate it. So as complicated as it could be for some, it's important that at least we enter the dialogue. And so, again, I just want to say thank you, Dr. Robert, for your time.

But that's part of what, you know, Stan, your question is that we're going to disseminate this information. And we told the participants in this study that we were going to disseminate it. So as complicated as it could be for some, it's important that at least we enter the dialogue. And so, again, I just want to say thank you, Dr. Robert, for your time.

So let me start this out, because I went back and looked at the shows, and on January the 1st, Dr. D talked to us about this topic around fentanyl. And fentanyl was a, and this was, yeah, January the 1st, so that was the beginning of the year. And it really was important for me to be a part of that because we're dealing a lot with substance abuse disorders.

So let me start this out, because I went back and looked at the shows, and on January the 1st, Dr. D talked to us about this topic around fentanyl. And fentanyl was a, and this was, yeah, January the 1st, so that was the beginning of the year. And it really was important for me to be a part of that because we're dealing a lot with substance abuse disorders.

I was really excited to hear what he had to say as well as to listen to some of the data. And I utilized some of that data in order to help me personally as well as my organization.

I was really excited to hear what he had to say as well as to listen to some of the data. And I utilized some of that data in order to help me personally as well as my organization.

position ourselves to try to address that issue in our community so that was the first show for the new year and it was one that was really really important for me and uh you know i was really excited that we were able to to book him yeah you know you know what else really struck me um and perhaps everybody can can remember this is war broke out in in ukraine

position ourselves to try to address that issue in our community so that was the first show for the new year and it was one that was really really important for me and uh you know i was really excited that we were able to to book him yeah you know you know what else really struck me um and perhaps everybody can can remember this is war broke out in in ukraine

Yeah, I think... One of the things that I liked about Health Chatter, number one, was the fact that it did allow us the opportunity to engage others into the conversation. It also allowed us to safely take a look at issues that we were personally involved in.

Yeah, I think... One of the things that I liked about Health Chatter, number one, was the fact that it did allow us the opportunity to engage others into the conversation. It also allowed us to safely take a look at issues that we were personally involved in.

For example, I think that because you and I talk a lot about being more seasoned, Stan, you know, having topics, you know, around aging and having topics around, for me, the topic is around strokes and

For example, I think that because you and I talk a lot about being more seasoned, Stan, you know, having topics, you know, around aging and having topics around, for me, the topic is around strokes and